Evaluation of the efficacy of a new low-level laser therapy home protocol in the treatment of temporomandibular joint disorder-related pain: A randomized, double-blind, placebo-controlled clinical trial

被引：30
|
作者：
Del Vecchio, Alessandro [1 ]
Floravanti, Miriam [1 ]
Boccassini, Armando [2 ]
Gaimari, Gianfranco [1 ]
Vestri, Annarita [3 ]
Di Paolo, Carlo [2 ]
Romeo, Umberto [1 ]
机构：
[1] Univ Rome, Dept Oral & Maxillo Facial Sci Sapienza, COU Oral Pathol & Med, Via Caserta 6, I-00161 Rome, Italy
[2] Univ Rome, Dept TMJ Dysfunct, Dept Oral & Maxillo Facial Sci Sapienza, Rome, Italy
[3] Policlin Umberto I Rome, Dept Publ Hlth & Infect Dis, Rome, Italy
来源：
CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE | 2021年 / 39卷 / 02期
关键词：
Temporomandibular disorders; laser therapy; photobiomodulation; pain management; laser; low-level laser therapy; MANAGEMENT; METAANALYSIS; DYSFUNCTION; MUSCLE;
D O I：
10.1080/08869634.2019.1599174
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
Objective: This study analyzed a home, low-level laser therapy (LLLT) protocol to manage temporomandibular joint disorders (TMJDs)-related pain. Methods: Ninety TMJD patients (12M, 78F) between 18 and 73 years were randomly subdivided into three groups. Study group (SG) received 1-week home protocol LLLT by B-cure Dental Pro: 808 nm, 5 J/min, 250 mW, 15 KHz for 8', 40 J each, over pain area, twice daily. Placebo group (PG) followed the same protocol using sham devices. Drugs group (DG) received conventional drugs. Pain was evaluated by visual analog scale (VAS) before and after therapy. Results: Statistical analysis showed that treatment was effective (F(2,83) = 4.882; p = .010). Bonferroni post-hoc analysis indicated a lower pain decrease in PG. SG registered a 34-point decrease per patient, while in PG and DG, the reduction was 25.6 and 35.3, respectively. Conclusion: The study supports the efficacy of home LLLT management of TMJD related pain.
引用
收藏
页码：141 / 150
页数：10
相关论文
共 50 条
  • [41] Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial
    Hoobehfekr, Saba
    Moghaddam, Hossein Sanjari
    Shalbafan, Mohammadreza
    Hashemi, Maryam Ghazizadeh
    Pirmoradi, Mohammad Mehdi
    Sakenian, Amirhossein
    Poopak, Amirhossein
    Kashefinejad, Shayan
    Yarahmadi, Masoomeh
    Akhondzadeh, Shahin
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 75 (02) : 57 - 62
  • [42] Efficacy of empagliflozin as adjunctive therapy to citalopram in major depressive disorder: a randomized double-blind, placebo-controlled clinical trial
    Zandifar, Atefeh
    Panahi, Maryam
    Badrfam, Rahim
    Qorbani, Mostafa
    BMC PSYCHIATRY, 2024, 24 (01)
  • [43] Efficacy and safety of pentoxifylline combination therapy in major depressive disorder: a randomized, double-blind, placebo-controlled clinical trial
    Farajollahi-Moghadam, Mostafa
    Sanjari-Moghaddam, Hossein
    Hasemi, Maryam Ghazizadeh
    Sanatian, Zahra
    Talaei, Ali
    Akhondzadeh, Shahin
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (03) : 140 - 146
  • [44] Double-blind randomized controlled trial of low-level laser therapy in carpal tunnel syndrome
    Irvine, J
    Chong, SL
    Amirjani, N
    Chan, KM
    MUSCLE & NERVE, 2004, 30 (02) : 182 - 187
  • [45] The evaluation of the efficacy of etofenamate spray in postoperative cesarean pain: Randomized, double-blind, placebo-controlled trial
    Erin, Kuebra Bak, I
    Erin, Recep
    Sahal, Safia Omar
    Kartal, Seyfi
    Kulaksiz, Deniz
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2023, 62 (05): : 697 - 701
  • [46] Efficacy of Individualized Homeopathic Medicines in the Treatment of Sciatica Pain: Double-Blind, Randomized, Placebo-Controlled Trial
    Das, Siddharth Kumar
    Basu, Trishita
    Tabassum, Saleema Naaz
    Sarkar, Ashish
    Ghosh, Shubhamoy
    Koley, Munmun
    Saha, Subhranil
    Nath, Arunava
    Khamrui, Srimanta
    JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2024, 30 (07): : 671 - 681
  • [47] Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial
    Bruun, Karin Due
    Amris, Kirstine
    Vaegter, Henrik Bjarke
    Blichfeldt-Eckhardt, Morten Rune
    Holsgaard-Larsen, Anders
    Christensen, Robin
    Toft, Palle
    TRIALS, 2021, 22 (01)
  • [48] Low-level laser therapy combined to functional exercise on treatment of fibromyalgia: a double-blind randomized clinical trial
    Daniel Germano Maciel
    Marianne Trajano da Silva
    José Antônio Rodrigues
    João Batista Viana Neto
    Ingrid Martins de França
    Ana Beatriz Medeiros Melo
    Therence Yves Pereira Barros da Silva
    Wouber Hérickson de Brito Vieira
    Lasers in Medical Science, 2018, 33 : 1949 - 1959
  • [49] Low-level laser therapy combined to functional exercise on treatment of fibromyalgia: a double-blind randomized clinical trial
    Maciel, Daniel Germano
    da Silva, Marianne Trajano
    Rodrigues, Jose Antonio
    Viana Neto, Joao Batista
    de Franca, Ingrid Martins
    Medeiros Melo, Ana Beatriz
    Pereira Barros da Silva, Therence Yves
    de Brito Vieira, Wouber Herickson
    LASERS IN MEDICAL SCIENCE, 2018, 33 (09) : 1949 - 1959
  • [50] Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial
    Karin Due Bruun
    Kirstine Amris
    Henrik Bjarke Vaegter
    Morten Rune Blichfeldt-Eckhardt
    Anders Holsgaard-Larsen
    Robin Christensen
    Palle Toft
    Trials, 22
12345